Home  Site Map  Contact Us
Search
About Us   Technology   Media   Applications   Clinical Trials   Publications   News & Events   Investors  
Home » Active Clinical Trials » Tourette Syndrome - Double-Blind Placebo Control Safety and Feasibility Study

Tourette Syndrome - Double-Blind Placebo Control Safety and Feasibility Study

Shalvata Mental Health Center, Hod-Hasharon, Israel

3 October, 2010

Contact: Amihai Gotliv; + (972) 09-747-8644, amihaigo@clalit.org.il
Principal Investigator: Prof. Yechiel Levkovitz
Related Links
Link to clinical trial
User Login
Keep me signed in
Copyright 2009 @ Brainsway. Address: 19 Hartum st. Bynet Building, 1st floor, Har Hotzvim, Jerusalem, ISRAEL, zip code: 91451 Tel: 972-2-5813140, Fax: 972-2-5812517, Email: info@brainsway.com

Created by Catom.